Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement company’s upstream ...
A global contract developer says it is among the first to offer a standardized approach to manufacturing adeno-associated viruses (AAVs) and lentiviruses (LVVs) for advanced therapies. AGC Biologics ...
This blog is based on the analysis Frost RadarTM: Digital Biomanufacturing of Viral Vectors Vandana Iyer from the TechVision – Health & Wellness team. As the cell and gene therapy (CGT) market ...
CBM to provide Asimov's clonal HEK293 viral vector production platform to clients for preclinical and clinical manufacturing Clonal HEK293 suspension cell line is GMP-banked and qualified, ready for ...
Although the targets of biomanufacturing have evolved from therapeutic proteins to “advanced therapies” and now to gene therapies, the issues and solutions remain the same. The production of safe, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results